Last Posted: Jul 24, 2020
- Effect of CYP2D6 and CYP3A4 Genotypes on the Efficacy of Cholinesterase Inhibitors in Southern Chinese Patients With Alzheimer's Disease.
Ma Suk Ling et al. American journal of Alzheimer's disease and other dementias 2019 34(5) 302-307 - Reserve and Alzheimer's disease genetic risk: Effects on hospitalization and mortality.
Filshtein Teresa Jenica et al. Alzheimer's & dementia : the journal of the Alzheimer's Association 2019 15(7) 907-916 - Blood DNA methylation signatures to detect dementia prior to overt clinical symptoms
PD Fransquet et al, Blood Based Biomarkers, July 2020 - Artificial Intelligence for Caregivers of Persons with Alzheimer's Disease and Related Dementias: A Systematic Literature Review.
Xie Bo et al. JMIR medical informatics 2020 Jun - A Comprehensive Machine-Learning Model Applied to Magnetic Resonance Imaging (MRI) to Predict Alzheimer's Disease (AD) in Older Subjects.
Battineni Gopi et al. Journal of clinical medicine 2020 Jul 9(7) - The Alzheimer Precision Medicine Initiative.
Hampel Harald et al. Journal of Alzheimer's disease : JAD 2019 68(1) 1-24 - Machine Learning Models Reveal the Importance of Clinical Biomarkers for the Diagnosis of Alzheimer's Disease.
Refaee Mahmoud Ahmed et al. Studies in health technology and informatics 2020 Jun 272478-481 - Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
Kim Hyug-Gi et al. Current Alzheimer research 2020 Jun - Using Unsupervised Learning to Identify Clinical Subtypes of Alzheimer's Disease in Electronic Health Records.
Alexander Nonie et al. Studies in health technology and informatics 2020 Jun 270499-503 - Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease
NS Raghavan et al, JAMA Neurology, June 22, 2020
.png)
No hay comentarios:
Publicar un comentario